Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

US Patent 11612652 · Granted Mar 28, 2023

Estimated economic value: $3,846,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dynamic provision of software application features2025
System and method for gradual migration from a legacy application to a replaceme2025
Methods of modulating immune responses with cationic lipid vaccine compositions2025
Stimulation of an immune response by cationic lipids2024
Vaccine compositions and methods of use2024
Vaccine compositions and methods of use2024
Stimulation of an immune response by enantiomers of cationic lipids2023
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vi2023
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vi2023
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vi2023
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vi2023
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vi2023